Inventiva (IVA) Total Current Liabilities (2018 - 2025)

Inventiva's (IVA) quarterly Total Current Liabilities came in at $90.1 million in Q4 2025, down 30.18% year-on-year from $129.0 million in Q4 2024, and down 99.86% quarter-over-quarter from $66.2 billion in Q2 2025.

Inventiva (IVA) Total Current Liabilities (2018 - 2025) Analysis & Trends

Inventiva's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $90.1 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 30.18% year-over-year to $90.1 million in Q4 2025; TTM through Dec 2025 was $90.1 million, a 30.18% decrease from a year earlier, with the FY2025 full-year figure at $90.1 million, down 30.18% from the prior year.
  • Total Current Liabilities declined to $90.1 million in Q4 2025 per IVA's latest filing, from $66.2 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $66.2 billion in Q2 2025 and bottomed at $20460.9 in Q2 2024.
  • The 5-year median for Total Current Liabilities is $31.3 million (2022), against an average of $8.4 billion.
  • Across the five-year window, Total Current Liabilities sank 35.5% in 2021 and surged 323408039.58% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $26.1 million in 2021, then rose by 19.81% to $31.3 million in 2022, then soared by 72.29% to $54.0 million in 2023, then soared by 139.06% to $129.0 million in 2024, then slumped by 30.18% to $90.1 million in 2025.
  • Per Business Quant, the three latest IVA Total Current Liabilities figures stand at $90.1 million (Q4 2025), $66.2 billion (Q2 2025), and $129.0 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Inventiva 842.48 Mn 842.48 Mn - 90.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 90.07 Mn
Jun 30, 2025 66.17 Bn
Dec 31, 2024 129.01 Mn
Jun 30, 2024 20,460.86
Dec 31, 2023 53.97 Mn
Oct 11, 2023 10.41 Mn
Dec 31, 2022 31.32 Mn
Jun 30, 2022 25.66 Bn
Dec 31, 2021 26.14 Mn
Jun 30, 2021 17.91 Mn
Mar 31, 2021 19.38 Mn
Dec 31, 2020 16.58 Mn
Jun 30, 2020 27.76 Mn
Dec 31, 2019 15.35 Mn
Dec 31, 2018 17.21 Mn